Indivior sales drop 9% on higher rebates; India's Alkem Labs plots $210M IPO;

@FiercePharma: ICYMI yesterday: FDA cites Pfizer for shortfalls at Chinese manufacturing plant. Article | Follow @FiercePharma

@CarlyHFierce: ICYMI yesterday: Express Scripts looks into pharmacies at AbbVie, Teva in wake of Valeant's Philidor saga. Article | Follow @CarlyHFierce

The Reckitt Benckiser pharma spinoff Indivior saw sales decline 9% for the first nine months of 2015, to $766 million from $844 million last year; the company cited lower market share and higher rebates as causes. Release

The Indian drugmaker Alkem Laboratories is planning an initial public offering worth about $210 million, hoping to launch it next month. Report

Merck KGaA's extended-release form of Glucophage won a new approval for diabetes patients with moderate kidney insufficiency and chronic heart failure. Release

Medical Device News

@FierceMedDev: ICYMI: Drug-device combo from Wyss takes a new approach on treating stroke. FierceBiotechResearch story | Follow @FierceMedDev

**@EmilyWFierce:**Flowonix teams with Connecticut provider for implant of drug delivery infusion pump. Article | Follow @EmilyWFierce

Neuromodulator and artificial kidney to be reviewed under FDA's Expedited Access Pathway. More

Fractyl gains traction with balloon ablation device for Type 2 diabetes. Article

Biotech News

@FierceBiotech: ICYMI yesterday: Merck KGaA inks cancer metabolism drug discovery alliance with Selvita. Article | Follow @FierceBiotech

@JohnCFierce: Gates, Hopp back $110M megaround for CureVac's mRNA work. News | Follow @JohnCFierce

**@DamianFierce:**Wait can we reconvene Grantland just to deal with this image? More | Follow @DamianFierce

Sanofi inks a $1.5B deal to join BioNTech's growing list of oncology partners. Story

GSK forms Keytruda combo trial pact as it plots path to 20 filings by 2020. Article

Drug Delivery News

Amgen's Imlygic becomes first re-engineered virus to earn FDA approval as a cancer fighter. Item

Pfizer's sickle cell anemia candidate enters trials, to the delight of delivery partner Halozyme. Story

Imaging nanoparticle puts the heat to ovarian cancer cells. Article

Investigational drug enables faster absorption of bioresorbable drug-eluting stents. Report

Novartis' inhaler for COPD gets FDA approval. More

Pharma Manufacturing News

Bain-backed compounding upstart adds second Texas manufacturing facility. Item

Struggling Daiichi again stumbles with vaccine production. More

First prefab biologics plant goes up in China, in 11 days. Report

Roche completes Shanghai plant expansion, starts on new project. Story

FDA uncovers issues at Pfizer China plant after banning products from its JV partner. Article

Pharma Asia News

China State Council briefing outlines multilevel system for medical treatment. More

MabSpace gets $15M as Lilly Asian Ventures bets on immune approach. Story

China's WuXi PharmaTech, Gilead focus on analytical testing in wider partnership. Article

HK-based Chi-Med wraps up PhI healthy volunteer trial of HMPL 523. More

China's Biomab Holding, India's Cipla go separate ways on biosimilars. Report

And Finally... GlaxoSmithKline's ($GSK) HIV-focused joint venture ViiV Healthcare said two new injectable HIV-fighters met their 32-week goals in a Phase IIb study, with details to be unveiled at a future scientific meeting. Release